A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : Scl-Ab

Search Conditions:
Search Keyword : Scl-Ab
Search Method : Exact match.
Research Area:

Abbreviation: Scl-Ab
Appearance Frequency: 67 time(s)
Long forms: 9

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
sclerostin antibody
(37 times)
(21 times)
BMD (5 times)
SCI (4 times)
OB (3 times)
2012 Inhibition of sclerostin by systemic treatment with sclerostin antibody enhances healing of proximal tibial defects in ovariectomized rats.
sclerostin-neutralizing antibody
(8 times)
(4 times)
BMA (1 time)
BMAT (1 time)
CRTAP (1 time)
2014 Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model.
Sclerostin monoclonal antibody
(7 times)
(3 times)
ALN (1 time)
BMP-2 (1 time)
MAR (1 time)
2011 Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.
anti-sclerostin antibody
(5 times)
(2 times)
OI (2 times)
BMD (1 time)
WT (1 time)
2011 Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats.
sclerostin-neutralizing monoclonal antibody
(4 times)
(2 times)
BVF (2 times)
ABL (1 time)
EP (1 time)
2013 Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury.
anti-Scl antibody
(2 times)
(1 time)
Scl (2 times)
iPTH (1 time)
MM (1 time)
2014 The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b.
sclerostin using a monoclonal antibody
(2 times)
(1 time)
DKK1 (1 time)
DKK1-Ab (1 time)
2012 Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.
sclerostin by a targeted monoclonal antibody
(1 time)
(1 time)
hTNFtg mice (1 time)
2013 Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.
systemic administration of a monoclonal antibody
(1 time)
(1 time)
CFU (1 time)
MAR (1 time)
2016 Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats.